Abstract:OBJECTIVES: Cell-free DNA based non-invasive prenatal testing (NIPT) has been shown with closeto-diagnosis sensitivity and specificity in detecting fetal T21, T18, and T13. Future development of this technology focuses on detection of other chromosomal aneuploidies, and more importantly chromosome copy number variants (CNVs) and single-gene mutations. Validation studies were carried out to demonstrate the feasibility of detecting CNVs and single-gene disease by exploiting the cell-free DNA testing strategy and existing NIPT platforms. METHOD: For testing CNVs, 35 plasma samples with known fetal CNVs (>10 Mb in size) were recruited, together with 1077 plasma samples with normal fetal karyotypes as the control. The samples were blindly tested using the routine NIPT testing pipelines adopted at the clinical laboratories of BGI, and analyzed with the proprietary FCAPS protocol. Results were compared to the karyotyping results to calculate the sensitivity and specificity of the NIPT test. For testing single-gene disease, we developed a unique haplotype-assisted approach which was validated in a Maple Syrup Urine Disease (MSUD) case. In a trio family (father, mother in early pregnancy, and proband), targeted sequencing (180X) of the known genes causing MSUD was used to identify the disease causative mutations in the proband child and parents. At 13 gestational weeks, maternal plasma DNA and genomic DNA of the trio family were tested with a customized array at the sequencing depth of 40X and 20X respectively to retrieve the SNPs information for the purpose of parental haplotypes deduction. Linkage analysis and Hidden Markov Model were then used to construct the fetal genotype and haplotype flanking the MSUD mutation region. RESULTS: For CNV detection, with on average 4–5 M reads per sample and the existing NIPT platforms, we were able to use the FCAPS analytic protocol to identify 32 positive samples in total of 35, and generated 6 false positive cases, leading to overall sensitivity and specificity of 91.4% and 99.4% respectively. False positive rate and false negative rate of the test were 0.56% and 0.28% respectively. We also showed that with an increased sequencing depth, the detection power of the test can be further improved. In the MUSD case, deep targeted sequencing in the trio family identified that the proband child carries a missense mutation and a large deletion on BCKDHA gene, which were inherited from the mother and father respectively. With the SNP markers of the proband and parents, parental haplotype of chromosome 19 in 6148 loci were recovered. After fetal haplotype construction, the same alleles as that of the proband in the causative gene BCKDHA were inherited to the fetus, indicating that the fetus is a MSUD patient. This result was later confirmed by invasive diagnosis, and led to a well-informed decision after post-test counselling. CONCLUSIONS: We demonstrate the successful application of NIPT in detection of CNVs larger than 10 Mb without changing much to the current pipelines of aneuploidy detection. It has the potential to be integrated into the current NIPT test and offer extra benefits to the clinical service. The haplotype-assisted approach we developed requires minimum genetic information to accurately predict fetal condition. It has the clinical potential for noninvasive prenatal diagnosis of single gene disease for family with a proband child and seeks a second healthy child.

Identification of chromosomal abnormalities in miscarriages by CNV-Seq

Chromosomal copy number analysis on chorionic villus samples from early spontaneous miscarriages by high throughput genetic technology

A Copy Number Variation Genotyping Method for Aneuploidy Detection in Spontaneous Abortion Specimens.

Expanding the Scope of Non-invasive Prenatal Testing to Detect Fetal Chromosomal Copy Number Variations

Chromosomal Copy Number Variations in Miscarriages and the Geneic Counseling of Recurrent Pregnancy Loss

Noninvasive detection of chromosomal CNV and single gene disease by massively parallel sequencing of cfDNA

Analysis of potential copy-number variations and genes associated with first-trimester missed abortion

A Novel System for the Detection of Spontaneous Abortion-Causing Aneuploidy and Its Erroneous Chromosome Origins Through the Combination of Low-Pass Copy Number Variation Sequencing and NGS-Based STR Tests.

The chromosomal characteristics of spontaneous abortion and its potential associated copy number variants and genes

Application of Copy Number Variation Sequencing Technology in 422 Foetuses with Abnormal Ultrasound Soft Markers

Application of CNVplex combined with STR assay for genetic etiology exploration in chorionic villus of recurrent spontaneous abortion

Analysis of copy number variants detected by sequencing in spontaneous abortion

Detection for Chromosomal Aberrations in Early Spontaneous Miscarriages Following Different Fertilization Methods

Copy number variation sequencing for the products of conception: What is the optimal testing strategy

Genetic Analysis of First‐trimester Miscarriages with a Combination of Cytogenetic Karyotyping, Microsatellite Genotyping and Arraycgh

Copy Number Variation Analysis of Euploid Pregnancy Loss

Identification of Minor Chromosomal Defects Causing Abnormal Foetus and Spontaneous Abortions

Genome Sequencing Explores Complexity of Chromosomal Abnormalities in Recurrent Miscarriage.

Non-invasive Prenatal Testing Reveals Copy Number Variations Related to Pregnancy Complications

Characterization of Copy-Number Variations and Possible Candidate Genes in Recurrent Pregnancy Losses

Investigation on combined copy number variation sequencing and cytogenetic karyotyping for prenatal diagnosis